← FDA DRUG APPROVALS

FDA ANDA · ANDA214055

SELEXIPAG

Sponsor: RK PHARMA

APPLICATION
ANDA214055
TYPE
ANDA
ORIGINAL APPROVAL
2026-04-16
LATEST ACTION
2026-04-16
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

SELEXIPAGPrescription
SELEXIPAG 1.4MG · TABLET · ORAL
SELEXIPAGPrescription
SELEXIPAG 1MG · TABLET · ORAL
SELEXIPAGPrescription
SELEXIPAG 0.6MG · TABLET · ORAL
SELEXIPAGPrescription
SELEXIPAG 0.2MG · TABLET · ORAL
SELEXIPAGPrescription
SELEXIPAG 1.6MG · TABLET · ORAL
SELEXIPAGPrescription
SELEXIPAG 1.2MG · TABLET · ORAL
SELEXIPAGPrescription
SELEXIPAG 0.8MG · TABLET · ORAL
SELEXIPAGPrescription
SELEXIPAG 0.4MG · TABLET · ORAL

Approval history

2026-04-16UNKNOWN · Original · standardLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →